All Stories

  1. A Novel Anti-PcrV Antibody Providing Enhanced Protection against Pseudomonas aeruginosa in Multiple Animal Infection Models

    Article • Antimicrobial Agents and Chemotherapy, May 2014, ASM Journals

    Charles Kendall Stover

  2. Expression of Foreign Genes in Mycobacteria

    Article • April 2014, ASM Journals

    Charles Kendall Stover

  3. Assessment of an Anti-Alpha-Toxin Monoclonal Antibody for Prevention and Treatment of Staphylococcus aureus-Induced Pneumonia

    Article • Antimicrobial Agents and Chemotherapy, December 2013, ASM Journals

    Charles Kendall Stover

  4. Epitope Mapping of Monoclonal Antibodies using Synthetic Oligosaccharides Uncovers Novel Aspects of Immune Recognition of the Psl Exopolysaccharide ofPseudomonas aeruginosa

    Article • Chemistry - A European Journal, November 2013, Wiley

    Charles Kendall Stover

  5. Staphylococcus aureus Alpha Toxin Suppresses Effective Innate and Adaptive Immune Responses in a Murine Dermonecrosis Model

    Article • PLoS ONE, October 2013, PLOS

    Charles Kendall Stover

  6. Identification of broadly protective human antibodies to Pseudomonas aeruginosa exopolysaccharide Psl by phenotypic screening

    Article • The Journal of Experimental Medicine, June 2012, Rockefeller University Press

    Charles Kendall Stover

  7. Identification of Anti-Alpha Toxin Monoclonal Antibodies That Reduce the Severity of Staphylococcus aureus Dermonecrosis and Exhibit a Correlation between Affinity and Potency

    Article • Clinical and Vaccine Immunology, January 2012, ASM Journals

    Charles Kendall Stover

  8. Discovery of Antibacterial Biotin Carboxylase Inhibitors by Virtual Screening and Fragment-Based Approaches

    Article • ACS Chemical Biology, May 2009, American Chemical Society (ACS)

    Charles Kendall Stover

  9. Development of a liquid chromatography/mass spectrometry-based drug accumulation assay in Pseudomonas aeruginosa

    Article • Analytical Biochemistry, February 2009, Elsevier

    Charles Kendall Stover

  10. Structural evidence for substrate-induced synergism and half-sites reactivity in biotin carboxylase

    Article • Protein Science, October 2008, Wiley

    Charles Kendall Stover, Dr Artem Evdokimov

  11. Molecular Validation of LpxC as an Antibacterial Drug Target in Pseudomonas aeruginosa

    Article • Antimicrobial Agents and Chemotherapy, June 2006, ASM Journals

    Charles Kendall Stover

  12. Loss of hemolysin expression in Staphylococcus aureus agr mutants correlates with selective survival during mixed infections in murine abscesses and wounds

    Article • FEMS Immunology & Medical Microbiology, August 2003, Oxford University Press (OUP)

    Charles Kendall Stover

  13. Potent, Novel in Vitro Inhibitors of thePseudomonasaeruginosaDeacetylase LpxC

    Article • Journal of Medicinal Chemistry, June 2002, American Chemical Society (ACS)

    Charles Kendall Stover

  14. Safety and immunogenicity of recombinant Bacille Calmette-Guérin (rBCG) expressing Borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adult volunteers: a candidate Lyme disease vaccine

    Article • Vaccine, February 1999, Elsevier

    Charles Kendall Stover

  15. AhpC, oxidative stress and drug resistance inMycobacterium tuberculosis

    Article • BioFactors, January 1999, Wiley

    Charles Kendall Stover

  16. Staphylococcus aureusgenetic loci impacting growth and survival in multiple infection environments

    Article • Molecular Microbiology, October 1998, Wiley

    Charles Kendall Stover

  17. Isoniazid resistance and tuberculosis

    Article • Biomedicine & Pharmacotherapy, January 1997, Elsevier

    Charles Kendall Stover

  18. Biochemical and Genetic Data Suggest that InhA Is Not the Primary Target for Activated Isoniazid in Mycobacterium tuberculosis

    Article • The Journal of Infectious Diseases, November 1996, Oxford University Press (OUP)

    Charles Kendall Stover

  19. Compensatory ahpC Gene Expression in Isoniazid-Resistant Mycobacterium tuberculosis

    Article • Science, June 1996, American Association for the Advancement of Science

    Charles Kendall Stover

  20. Chapter 17. Recent Advances in the Chemistry and Biology of Anti-mycobacterial Agents

    Article • January 1996, Elsevier

    Charles Kendall Stover

  21. Bacterial Vaccine Vectors and Bacillus Calmette-Guerin

    Article • Clinical Infectious Diseases, April 1995, Oxford University Press (OUP)

    Charles Kendall Stover

  22. Systemic and mucosal immunity induced by BCG vector expressing outer-surface protein A of Borrelia burgdorferi

    Article • Nature, December 1994, Springer Science + Business Media

    Charles Kendall Stover

  23. Recombinant vaccine delivery systems and encoded vaccines

    Article • Current Opinion in Immunology, August 1994, Elsevier

    Charles Kendall Stover

  24. Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine

    Article • The Journal of Experimental Medicine, July 1993, Rockefeller University Press

    Charles Kendall Stover

  25. Use of Recombinant BCG as a Vaccine Delivery Vehicle

    Article • January 1992, Springer Science + Business Media

    Charles Kendall Stover

  26. Molecular cloning and sequence analysis of a Rickettsia tsutsugamushi 22 kDa antigen containing B- and T-cell epitopes

    Article • Microbial Pathogenesis, July 1991, Elsevier

    Charles Kendall Stover

  27. New use of BCG for recombinant vaccines

    Article • Nature, June 1991, Springer Science + Business Media

    Charles Kendall Stover

  28. Detection of Rickettsia tsutsugamushi by Gene AmpUcation Using Polymerase Chain Reaction Techniques"

    Article • Annals of the New York Academy of Sciences, June 1990, Wiley

    Charles Kendall Stover

  29. Use of conversion adaptors to clone antigen genes in λgt11

    Article • Analytical Biochemistry, June 1987, Elsevier

    Charles Kendall Stover